Pfizer earnings were $4.3B for the trailing 12 months ending Sep 29, 2024, with -58.9% growth year over year. The latest PFE earnings report on Sep 29, 2024 announced Q3 2024 earnings of $4.5B, up 10,790.2% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, PFE reported annual earnings of $2.1B, with -93.2% growth.
PFE past earnings growth
How has PFE's earnings growth performed historically?
On PFE's earnings call on Invalid Date, Pfizer (NYSE: PFE) reported Q3 2024 earnings per share (EPS) of $0.79, up 288.1% year over year. Total PFE earnings for the quarter were $4.47 billion. In the same quarter last year, Pfizer's earnings per share (EPS) was -$0.42.
As of the last Pfizer earnings report, Pfizer is currently profitable. Pfizer's net profit (also called net income) for the twelve months ending Sep 29, 2024 was $4.25 billion, a 59.44% decrease year over year.
What was PFE's earnings growth in the past year?
As of Pfizer's earnings date in Invalid Date, Pfizer's earnings has grown -58.92% year over year. This is 67.71 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 8.79%. PFE earnings in the past year totalled $4.25 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.